Jitsubo
2005
FOUNDED
M&A
STATUS
Later Stage VC
LATEST DEAL TYPE
2
INVESTORS
Description
Developer of peptide generic products intended to contribute to the well-being of society through innovative peptide therapeutics. The company's peptide generic products address unmet medical needs and administer to the sustainable development of medical care to synthesize peptides in high-quality and at lower costs compared to existing methods.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Parent Company
Primary Office
- Naka-cho 2-24-16
- Nokodai Tamakoganei Ventueport 304
- Koganei, Tokyo 184-0012
- Japan
+81 000-000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Jitsubo’s full profile, request a free trial.
Jitsubo Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 11-Nov-2016 | Completed | Generating Revenue | |||
| 1. Merger/Acquisition | 26-Dec-2014 | 00.000 | 00.000 | Completed | Generating Revenue |
Jitsubo Executive Team (6)
2 Former Executives
You’re viewing 4 of 6 executives. Get the full list »Jitsubo Board Members (6)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Hideo Shiba | Self | Audit & Supervisory Board Member | 000 0000 | |
| Kenji Maekawa | Self | External Audit & Supervisory Board Member | 000 0000 | |
| Kiichiro Ohya | Universal Materials Incubator | Board Member | 000 0000 | |
| Manabu Nakamura | Self | Board Member | 000 0000 | |
| Tadayoshi Yasui | Self | Board Member | 000 0000 |